Nausheen Fathima Mahmood, | |
505 Parnassus Ave, San Francisco, CA 94143-2204 | |
(415) 476-3891 | |
Not Available |
Full Name | Nausheen Fathima Mahmood |
---|---|
Gender | Female |
Speciality | Psychiatry & Neurology - Epilepsy |
Location | 505 Parnassus Ave, San Francisco, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013408970 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084E0001X | Psychiatry & Neurology - Epilepsy | A167095 (California) | Primary |
Entity Name | University Of California San Francisco |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
"Hope for Haiti Now" (HFHN) today announced the distribution of $35M as the first installment of funds raised through the January 22nd telethon: "Hope for Haiti Now: A Global Benefit for Earthquake Relief." Six of the telethon beneficiaries (Oxfam America, Partners In Health, the American Red Cross, UNICEF, United Nations World Food Programme, and Yele Haiti Foundation) submitted proposals last week.
During the 1970s and 1980s, researchers and policymakers became increasingly worried about multiple consequences of acidic emissions of sulfur dioxide and nitrogen oxides from the stacks of power stations, and eventually they were controlled. In Europe, there was much concern about the effects on Sweden's many lakes, which were found to be in some cases strikingly acidic.
Survey data suggest at least 1 in 10 U.S. adults are food allergic and nearly 1 in 5 believe they have a food allergy. Food allergies are expensive and potentially life-threatening conditions.
U.N. Secretary-General Ban Ki-moon this week "called on the global community to act quickly to address what he described as a 'cascading crisis' sweeping the Sahel region of West Africa, where 15 million people have been affected by the drought and conflict-related crisis in the area," the U.N. News Centre reports.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
› Verified 5 days ago
Entity Name | Ucsf Medical Group Business Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
"Hope for Haiti Now" (HFHN) today announced the distribution of $35M as the first installment of funds raised through the January 22nd telethon: "Hope for Haiti Now: A Global Benefit for Earthquake Relief." Six of the telethon beneficiaries (Oxfam America, Partners In Health, the American Red Cross, UNICEF, United Nations World Food Programme, and Yele Haiti Foundation) submitted proposals last week.
During the 1970s and 1980s, researchers and policymakers became increasingly worried about multiple consequences of acidic emissions of sulfur dioxide and nitrogen oxides from the stacks of power stations, and eventually they were controlled. In Europe, there was much concern about the effects on Sweden's many lakes, which were found to be in some cases strikingly acidic.
Survey data suggest at least 1 in 10 U.S. adults are food allergic and nearly 1 in 5 believe they have a food allergy. Food allergies are expensive and potentially life-threatening conditions.
U.N. Secretary-General Ban Ki-moon this week "called on the global community to act quickly to address what he described as a 'cascading crisis' sweeping the Sahel region of West Africa, where 15 million people have been affected by the drought and conflict-related crisis in the area," the U.N. News Centre reports.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Nausheen Fathima Mahmood, 505 Parnassus Ave, Box 0114, San Francisco, CA 94143 Ph: () - | Nausheen Fathima Mahmood, 505 Parnassus Ave, San Francisco, CA 94143-2204 Ph: (415) 476-3891 |
News Archive
"Hope for Haiti Now" (HFHN) today announced the distribution of $35M as the first installment of funds raised through the January 22nd telethon: "Hope for Haiti Now: A Global Benefit for Earthquake Relief." Six of the telethon beneficiaries (Oxfam America, Partners In Health, the American Red Cross, UNICEF, United Nations World Food Programme, and Yele Haiti Foundation) submitted proposals last week.
During the 1970s and 1980s, researchers and policymakers became increasingly worried about multiple consequences of acidic emissions of sulfur dioxide and nitrogen oxides from the stacks of power stations, and eventually they were controlled. In Europe, there was much concern about the effects on Sweden's many lakes, which were found to be in some cases strikingly acidic.
Survey data suggest at least 1 in 10 U.S. adults are food allergic and nearly 1 in 5 believe they have a food allergy. Food allergies are expensive and potentially life-threatening conditions.
U.N. Secretary-General Ban Ki-moon this week "called on the global community to act quickly to address what he described as a 'cascading crisis' sweeping the Sahel region of West Africa, where 15 million people have been affected by the drought and conflict-related crisis in the area," the U.N. News Centre reports.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
› Verified 5 days ago
Dr. Mary Susan Hansen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 295 Fell St, Suite A, San Francisco, CA 94102 Phone: 415-648-3291 | |
Kristie Boyce, MD, MPH Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 333 Hayes St, Suite 210, San Francisco, CA 94102 Phone: 415-484-9259 Fax: 415-484-9259 | |
Connie Lee, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 401 Parnassus Ave, Box 0984, San Francisco, CA 94143 Phone: 415-476-7000 | |
Dr. Shulamit Glaubach, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1939 Divisadero St, Suite 4c, San Francisco, CA 94115 Phone: 415-440-6505 | |
Jacob Moulds, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3061 Fillmore St, San Francisco, CA 94123 Phone: 415-292-3440 | |
Jack C Rose, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2100 Webster St, 4th Floor, San Francisco, CA 94115 Phone: 415-600-5760 | |
Dr. Yvonne W Wu, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 400 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-2813 |